Provided by Tiger Trade Technology Pte. Ltd.

Amgen

384.32
+16.524.49%
Post-market: 383.80-0.5200-0.14%19:57 EST
Volume:3.84M
Turnover:1.46B
Market Cap:206.95B
PE:27.01
High:385.12
Open:369.99
Low:368.90
Close:367.80
52wk High:385.12
52wk Low:261.43
Shares:538.48M
Float Shares:536.99M
Volume Ratio:1.05
T/O Rate:0.72%
Dividend:9.53
Dividend Rate:2.48%
EPS(TTM):14.23
EPS(LYR):14.23
ROE:106.10%
ROA:8.15%
PB:23.90
PE(LYR):27.01

Loading ...

Amgen (AMGN) Receives a Buy from Argus Research

TIPRANKS
·
Feb 07

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 07

Amgen Advances Xaluritamig Into Early-Stage Trial for Hard-to-Treat Ewing Sarcoma

TIPRANKS
·
Feb 07

Amgen Is Maintained at Neutral by Guggenheim

Dow Jones
·
Feb 06

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Feb 06

CORRECTED-CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5)

Reuters
·
Feb 06

Deutsche Bank Adjusts Amgen Price Target to $295 From $285, Maintains Hold Rating

MT Newswires Live
·
Feb 06

U.S. RESEARCH ROUNDUP-Alphabet, Corteva, Varonis Systems

Reuters
·
Feb 05

Cantor Fitzgerald Sticks to Its Hold Rating for Amgen (AMGN)

TIPRANKS
·
Feb 05

Amgen Earnings Call: Broad Growth Amid Manageable Risks

TIPRANKS
·
Feb 05

Health Care Up After Eli Lilly Earnings -- Health Care Roundup

Dow Jones
·
Feb 05

LIVE MARKETS-Nasdaq, S&P 500 fall on more tech weakness, Amgen buoys Dow

Reuters
·
Feb 05

Amgen Seen Driving Long-Term Growth on R&D Pipeline, Oppenheimer Says

MT Newswires Live
·
Feb 05

Amgen's Strong Core Growth Offsets Wait for Weightloss Drug -- Market Talk

Dow Jones
·
Feb 05

Amgen’s FORTITUDE-301 Cancer Trial Completion: What Investors Should Watch in Bemarituzumab’s Next Act

TIPRANKS
·
Feb 05

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2026-02-04

Reuters
·
Feb 05

Amgen Posts Q4 Beat, Recent Label Updates Suggest Upside To 2026 Estimates

Benzinga_recent_news
·
Feb 04

Stock Track | Amgen Soars 5.30% Intraday on Upbeat 2026 Profit Forecast and Strong Q4 Results

Stock Track
·
Feb 04

BUZZ-U.S. STOCKS ON THE MOVE-Bio-Techne, AbbVie, Johnson Controls

Reuters
·
Feb 04

Amgen price target raised to $360 from $335 at RBC Capital

TIPRANKS
·
Feb 04